Acarbose

阿卡波糖

Report date: 2026/02/18 20:02:09
NME

Base Information

Drug NameAcarbose
Drug Alias Nameacarbosa糖禄acarbosum阿卡糖Glucor +[9] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsHealthy AgingMetabolic SyndromeDiabetes Mellitus, Type 2 +[8] 
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryUnited States
Original Approved Date1995/09/06
Country/TerritoryCanadaUnited StatesGermany +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer Healthcare Company Ltd
Inactive CompaniesUT Health San AntonioGwt-Tud GmbhEms +[10] 
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsHealthy AgingMetabolic SyndromeDiabetes Mellitus +[7] 

Other Information

ATC CodeA10BF01
Related LinksWikipediaDrugBankKEGG